433 results about "Dry eyes" patented technology

Methods, kits, and compositions for treating dry eye disorders and other related eye diseases are provided, wherein the methods, kits, and compositions utilize a JAK inhibitor.

Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.

A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. The components of the controller and microstimulator may be implemented in a single unit or in separate devices. When implemented separately, the controller and microstimulator may communicate wirelessly or via a wired connection. The microstimulator may generate pulses from a controller signal and apply the signal via one or more electrodes to an anatomical target. The microstimulator may not have any intelligence or logic to shape or modify a signal. The microstimulator may be a passive device configured to generate a pulse based on a signal received from the controller. The microstimulator may shape or modify a signal. Waveforms having different frequency, amplitude and period characteristics may stimulate different anatomical targets in a patient.

This invention provides articles and methods for drug delivery including a hydrogel containing one or more drugs for the treatment of a posterior segment disease and/or dry eye conditions. Exemplary drugs are anti-angiogenesis compounds for the treatment of macular degeneration. Allowing passive transference of this drug from a dilute solution into the hydrogel produces the delivery system. The hydrogel, when placed in contact with the eye, delivers the drug. The delivery of the drug is sustained over an extended period of time, which is of particular utility in the eye, which is periodically flushed with tears. This sustained delivery accelerates the treatment process while avoiding potential damaging effects of localized delivery of high concentrations of compounds, e.g., from eye drops.

The invention relates to a drink, in particular to a chrysanthemum health drink strengthening immunity of organisms and suitable to be drunk by various groups, and a preparation method thereof. The honeysuckle health drink is prepared from the following raw materials in portion by weight: chrysanthemum, Chinese wolfberry, honey, citric acid and water of which the ratio is 10-30:5-15:25-45:0.1-1.0:200-400. The chrysanthemum health drink has scientific formula, simple preparation process, good color, aroma and taste, and rich nutrient and is suitable to be drunk by various groups for a long time; the chrysanthemum is adopted as a main raw material, can make people have clear head and bright eyes, and particularly has good treatment effect on excitable computer group with dry eyes caused by eye strain; and the chrysanthemum health drink also has the effects of improving liver function, clearing heat and releasing toxicity, resisting bacteria and diminishing inflammation, strengthening theimmunity and the like, and makes up for the deficiency that carbonated beverage, water, tea, milk and juice beverage only exist in the market but dietetic beverage is absent.

A manual device for massaging one or both of the upper and lower lids of the eye, the device comprising: a body, composed of flexible resilient biocompatible material, wherein the body provides jaws or lips, wherein the lips are biased into a spaced relationship by the material of the body, and wherein each lip is adapted to engage either the upper or lower eyelid, such that movement of the lips causes movement of at least one eyelid with respect to the other. The devices can conveniently be used to manipulate the meibomian glands of the eye in an optimum orientation, for example for alleviating or treating dry eye.

A dry eye treatment device and method of use are disclosed for applying heat to the exterior surface of the eyelid to treat dry eye caused by meibomian gland dysfunction (MGD). More specifically, a user operable main unit and hand piece are provided that allow the user to heat his/her or another patient's eyelids to a desired temperature, which can effectively and efficiently raise the temperature at the meibomian glands to a temperature sufficient to melt, loosen, or soften more serious occlusions or obstructions in the meibomian glands, and restore natural secretory function to obstructed glands.

A method for the mitigation of symptoms of dry eye is disclosed. The method involves at least (a) incorporating one or more non-functionalized polymers having one or more hydrophilic moieties into an ophthalmic device that is a polymerization product of a comonomer mixture comprising: (i) a major amount of a non-silicone-containing hydrophilic monomer; and (ii) an end terminal functionalized surfactant; and (b) inserting the ophthalmic device in the eye of a patient.

Eye drops for the treatment of dry eye is disclosed. The eye drops is a solution-type, emulsion-type or two separate phase-type eye drops containing squalane and is, among others, an oil-in-water-type emulsion further containing a water-soluble macromolecular compound such as polyvinylpyrrolidone. Also disclosed are use of squalane for the production of eye drops for the treatment of dry eye, and a method for the treatment of dry eye.

The present invention relates to a compound of the Formula (I)):

or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.

The invention relates to the technical field of eye dressings and in particular relates to a medical biological eye cold therapy dressing and a preparation method thereof. The medical biological eye cold therapy functional dressing is prepared from the following components: sorbitol, hyaluronic acid, pearl powder, peppermint oil, borneol, a mother chrysanthemum extracting solution, cassia seed extractive and a balsam pear extracting solution. The medical biological eye cold therapy dressing has functions of diminishing inflammation and swelling, easing pain and keeping moist of eyes for a long time, is used for improving and auxiliary treating of symptoms of dry eyes, eyestrain, eye itching, eye swelling, black eyes, lacrimation, secretion increase, asthenopia, corneal ulcer and the like caused by reasons of myopia, cataract, presbyopia, glaucoma, excessive eye and the like and has function of improving amblyopia.

The present invention relates to topical ophthalmic compositions for treating or preventing epithelial lesions or ophthalmic disorders, including dry eye or keratoconjunctivitis sicca.

The present invention relates to a method for treating dry eye disease. The method comprises identifying a subject suffering from dry eye disease, and administering to the subject an amount of azithromycin effective to reduce dry eye symptoms and/or signs ands to improve tear film quality. Azithromycin is preferably administered topically to the subject in an aqueous ophthalmic solution comprises 0.5-1.5% (w/v) azithromycin in a polymeric suspension.

The invention discloses a Chinese medicine composition for treating ablepsia and a preparation method thereof. The Chinese medicine composition is mainly formed by the following raw medicine materials: cassia seed, rhizoma atractylodis, Cassia occidentalis, abalone shell, chrysanthemum, kudzu-vine root, Radix achyranthis Bidentatae, flesh rehmannia, Scutellaria baicalensis, coptis, notopterygium root, Ligusticum wallichii, cassia twig, Salvia miltiorrhiza Bunge, motherwort herb, Gastrodia elata Blume, Rhizoma acori Graminei, Chinese angelica, radix trichosanthis, red paeony root, white paeony root, angelica root, pseudo-ginseng and the like. The Chinese medicine composition of the invention can be prepared into any kind of common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composition can obviously improve serious hypopsia even blindness and ablepsia with symptoms such as dry eyes, dizziness and tinnitus, eyeball swollen pain, dizziness and chest stuffiness, nausea and vomiting and the like, and has the advantages of exact clinical curative effect, obvious curative effect, rapid effect, low cost, basically no toxic side effect and the like.